APA (7th ed.) Citation

Lu, D., Ruan, Y., Zhou, F., Ma, Y., Chang, J., Wei, Y., . . . Shen, X. (2025). Desloratadine as the selective 5HT2AR antagonist suppresses neutrophil extracellular traps formation to ameliorate diabetic peripheral neuropathy pathology. Journal of Neuroinflammation, 22(1), 1. https://doi.org/10.1186/s12974-025-03581-6

Chicago Style (17th ed.) Citation

Lu, Dayun, Yuan Ruan, Fan Zhou, Yan Ma, Jieru Chang, Yuxi Wei, Rui Xu, Jiaying Wang, and Xu Shen. "Desloratadine as the Selective 5HT2AR Antagonist Suppresses Neutrophil Extracellular Traps Formation to Ameliorate Diabetic Peripheral Neuropathy Pathology." Journal of Neuroinflammation 22, no. 1 (2025): 1. https://doi.org/10.1186/s12974-025-03581-6.

MLA (9th ed.) Citation

Lu, Dayun, et al. "Desloratadine as the Selective 5HT2AR Antagonist Suppresses Neutrophil Extracellular Traps Formation to Ameliorate Diabetic Peripheral Neuropathy Pathology." Journal of Neuroinflammation, vol. 22, no. 1, 2025, p. 1, https://doi.org/10.1186/s12974-025-03581-6.